RxDoctor Payments Data

James Nitzkorski, MD

Surgical Oncology · Poughkeepsie, NYNPI 1245471986

Payments from drug & device makers

What this record shows

This record is dominated by education: $16,000 of the $17,777 with a category attached, or 90.0%. Intuitive Surgical accounts for 96.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $17,112 and has fallen 98.2% since, to $317 in 2025. Among surgical oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,777in general payments, 2019–2025

Across 25 payments — averaging $711.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$17K
  • Stryker$359
  • Regeneron Healthcare Solutions, Inc.$128
  • Kerecis Limited$49
  • Integra Lifesciences Corporation$39
  • Dilon Technologies, Inc.$38
  • plus $51 from 2 others
$32,400in research payments, 2019–2025

Across 1 payment — averaging $32,400 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$32K

What the payments were for

  • Travel & lodging$1,1096%
  • Food & beverage$6684%
  • Education$16,00090%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,777 in reported general payments places this provider in the 90th percentile of 173 surgical oncology providers in New York.

See all surgical oncology providers in New York

Medicare billing

Part B allowed, 2024
$127,207
Medicare patients
187
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →